Skip to main content
. 2020 Aug 17;43(9):1–9. doi: 10.1007/s40618-020-01229-1

Fig. 4.

Fig. 4

Distribution of patients between polyglandular autoimmune syndrome type II and III; the proportion of polyglandular autoimmune syndrome type III patients was significantly higher than that of polyglandular autoimmune syndrome type II patients